References
Bhandari M, Mathur W, Kumar R, et al. Surgical and advanced medical therapy for the treatment of type 2 diabetes in class I obese patients: a short-term outcome. Obes Surg. 2017;27(12):3267–72. https://doi.org/10.1007/s11695-017-2770-y.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/NEJMoa1600869.
McCambridge J, Sorhaindo A, Quirk A, et al. Patient preferences and performance bias in a weight loss trial with a usual care arm. Patient Educ Couns. 2014;95(2):243–7. https://doi.org/10.1016/j.pec.2014.01.003.
Lovshin JA. Glucagon-like Peptide-1 receptor agonists: a class update for treating type 2 diabetes. Can J Diabetes. 2017;41(5):524–35. https://doi.org/10.1016/j.jcjd.2017.08.242.
Mancini MC, de Melo ME. The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg. Diabetol Metab Syndr. 2017;9(1):44. https://doi.org/10.1186/s13098-017-0242-0.
Funding
The authors declare no financial support was received for this communication.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Claudia Analy Vélez-Viveros has nothing to disclose.
José Gerardo González-González reports personal fees and other from Novo Nordisk, outside the submitted work.
Marcela Rodríguez-Flores reports personal fees from Novo Nordisk, outside the submitted work.
Leonardo Mancillas-Adame reports personal fees from Novo Nordisk, outside the submitted work.
Rights and permissions
About this article
Cite this article
Velez-Viveros, C.A., González-González, J.G., Rodríguez-Flores, M. et al. Comparing Apples to Apples. Is it Fair to Compare Suboptimal Doses of Medications to Surgery?. OBES SURG 28, 850–851 (2018). https://doi.org/10.1007/s11695-017-3082-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-017-3082-y